Farr Miller & Washington Boosted Its Cvs Health (CVS) Holding; Profile of 8 Analysts Covering Juniper Networks, Inc. (JNPR)

February 19, 2018 - By Adrian Erickson

Among 32 analysts covering Juniper Networks Inc. (NYSE:JNPR), 8 have Buy rating, 4 Sell and 20 Hold. Therefore 25% are positive. Juniper Networks Inc. had 92 analyst reports since July 24, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Bank of America on Wednesday, October 25. The firm earned “Underweight” rating on Wednesday, January 31 by Barclays Capital. RBC Capital Markets maintained Juniper Networks, Inc. (NYSE:JNPR) rating on Wednesday, September 6. RBC Capital Markets has “Hold” rating and $30.0 target. The firm earned “Buy” rating on Monday, October 5 by Stifel Nicolaus. The firm has “Neutral” rating given on Tuesday, April 12 by UBS. The stock of Juniper Networks, Inc. (NYSE:JNPR) has “Market Perform” rating given on Monday, May 23 by William Blair. UBS maintained it with “Buy” rating and $32 target in Friday, July 24 report. The rating was downgraded by Bernstein on Monday, January 9 to “Mkt Perform”. The company was maintained on Wednesday, January 20 by RBC Capital Markets. Raymond James upgraded the stock to “Outperform” rating in Friday, July 21 report. See Juniper Networks, Inc. (NYSE:JNPR) latest ratings:

07/02/2018 Broker: Goldman Sachs Rating: Neutral New Target: $26 Initiates Coverage On
31/01/2018 Broker: Cowen & Co Rating: Hold New Target: $25.0 Maintain
31/01/2018 Broker: Barclays Capital Old Rating: Underweight New Rating: Underweight Old Target: $25 New Target: $23 Maintain
31/01/2018 Broker: Stifel Nicolaus Old Rating: Hold New Rating: Hold Old Target: $28 New Target: $27 Maintain
31/01/2018 Broker: Nomura Old Rating: Neutral New Rating: Neutral Old Target: $26 New Target: $25 Maintain
30/01/2018 Broker: Loop Capital Rating: Hold New Target: $30 Initiates Coverage On
26/01/2018 Broker: M Partners Rating: Hold New Target: $31.0
22/01/2018 Broker: Oppenheimer Rating: Buy New Target: $33.0 Upgrade
17/01/2018 Broker: Barclays Capital Old Rating: Equal-Weight New Rating: Underweight Old Target: $28 Downgrade
10/01/2018 Broker: Piper Jaffray Rating: Hold New Target: $27.0 Maintain

Farr Miller & Washington Llc increased Cvs Health Corp (CVS) stake by 1.07% reported in 2017Q3 SEC filing. Farr Miller & Washington Llc acquired 4,640 shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The Farr Miller & Washington Llc holds 437,664 shares with $35.59 million value, up from 433,024 last quarter. Cvs Health Corp now has $72.84 billion valuation. The stock increased 2.00% or $1.41 during the last trading session, reaching $71.9. About 6.47M shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since February 19, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Investors sentiment decreased to 1.33 in Q3 2017. Its down 0.94, from 2.27 in 2017Q2. It fall, as 41 investors sold Juniper Networks, Inc. shares while 129 reduced holdings. 49 funds opened positions while 177 raised stakes. 330.80 million shares or 1.77% less from 336.77 million shares in 2017Q2 were reported. Dreman Value Mgmt L L C stated it has 0.24% in Juniper Networks, Inc. (NYSE:JNPR). Tiaa Cref Inv Mgmt Lc has 2.53 million shares for 0.05% of their portfolio. Usa Fin Portformulas Corporation invested 0.18% in Juniper Networks, Inc. (NYSE:JNPR). Da Davidson And Co invested 0% in Juniper Networks, Inc. (NYSE:JNPR). Highvista Strategies Limited Liability Company holds 0.13% or 20,000 shares. Thrivent For Lutherans stated it has 139,398 shares or 0.01% of all its holdings. Texas Permanent School Fund stated it has 0.04% of its portfolio in Juniper Networks, Inc. (NYSE:JNPR). Pictet Asset Management Ltd reported 227,122 shares. Hartford Investment invested 0.04% of its portfolio in Juniper Networks, Inc. (NYSE:JNPR). 38,208 were reported by Advantus Capital Management Incorporated. Strs Ohio has invested 0.01% in Juniper Networks, Inc. (NYSE:JNPR). Lombard Odier Asset Mgmt (Switzerland), a Switzerland-based fund reported 75,369 shares. Moreover, Pittenger And Anderson has 0% invested in Juniper Networks, Inc. (NYSE:JNPR). The Switzerland-based Credit Suisse Ag has invested 0.02% in Juniper Networks, Inc. (NYSE:JNPR). 19,645 were reported by Zacks Investment Mgmt.

Juniper Networks, Inc. designs, develops, and sells network services and products worldwide. The company has market cap of $9.88 billion. The firm offers various routing products, such as ACX series universal access routers to deploy new high-bandwidth services; MX series Ethernet routers that functions as a universal edge platform; PTX series packet transport routers; cloud customer premises equipment; and NorthStar controllers. It has a 32.94 P/E ratio. It also provides switching products, including EX series Ethernet switches to address the access, aggregation, and core layer switching requirements of micro branch, branch office, and campus and data center environments; QFX series of core, spine, and top-of-rack data center switches; and OCX1100, an open networking switch.

The stock decreased 2.08% or $0.56 during the last trading session, reaching $26.35. About 5.78 million shares traded or 5.19% up from the average. Juniper Networks, Inc. (NYSE:JNPR) has risen 32.01% since February 19, 2017 and is uptrending. It has outperformed by 15.31% the S&P500.

Since August 28, 2017, it had 0 buys, and 2 selling transactions for $456,153 activity. rahim rami sold $438,944 worth of stock. SPIDELL TERRANCE F sold $17,209 worth of stock.

Since August 23, 2017, it had 0 buys, and 5 selling transactions for $38.09 million activity. The insider Moriarty Thomas M sold 90,267 shares worth $7.19 million. Roberts Jonathan C had sold 85,743 shares worth $7.13M. Foulkes Helena had sold 39,340 shares worth $3.22M. 241,150 CVS Health Corporation (NYSE:CVS) shares with value of $20.03M were sold by MERLO LARRY J. $18.88 million worth of CVS Health Corporation (NYSE:CVS) was sold by Denton David M on Monday, September 11.

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 72 analyst reports since July 22, 2015 according to SRatingsIntel. As per Thursday, December 17, the company rating was downgraded by Goldman Sachs. The stock of CVS Health Corporation (NYSE:CVS) earned “Buy” rating by Tigress Financial on Tuesday, December 26. The stock of CVS Health Corporation (NYSE:CVS) has “Buy” rating given on Thursday, January 4 by Raymond James. The firm earned “Neutral” rating on Friday, November 3 by Citigroup. The stock of CVS Health Corporation (NYSE:CVS) has “Hold” rating given on Friday, September 15 by Jefferies. Oppenheimer maintained CVS Health Corporation (NYSE:CVS) on Thursday, December 17 with “Outperform” rating. The rating was maintained by Robert W. Baird with “Hold” on Friday, October 27. The rating was maintained by Cowen & Co with “Buy” on Tuesday, June 13. The firm earned “Neutral” rating on Monday, May 9 by Citigroup. The rating was maintained by Robert W. Baird with “Hold” on Thursday, January 4.

Investors sentiment decreased to 0.88 in Q3 2017. Its down 0.04, from 0.92 in 2017Q2. It worsened, as 60 investors sold CVS shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. Green Square Ltd Limited Liability Company holds 0.17% of its portfolio in CVS Health Corporation (NYSE:CVS) for 11,404 shares. Pettyjohn Wood & White Inc owns 71,155 shares or 2.15% of their US portfolio. Kcm Advsr Limited Liability Corp has 0.18% invested in CVS Health Corporation (NYSE:CVS) for 36,547 shares. Whittier Trust Of Nevada, a Nevada-based fund reported 64,049 shares. Fred Alger reported 28,255 shares stake. E&G Advisors Limited Partnership reported 5,171 shares stake. Peddock Capital Ltd reported 15,633 shares stake. Sg Americas Secs Limited Liability has 32,954 shares. Tower Bridge stated it has 1.57% of its portfolio in CVS Health Corporation (NYSE:CVS). Appleton Ptnrs Inc Ma owns 14,380 shares for 0.2% of their portfolio. Aviance Limited Liability holds 0.01% of its portfolio in CVS Health Corporation (NYSE:CVS) for 971 shares. Cullinan Assoc invested 0.74% in CVS Health Corporation (NYSE:CVS). Folger Nolan Fleming Douglas Cap Management Inc has invested 0.1% of its portfolio in CVS Health Corporation (NYSE:CVS). Live Your Vision Llc stated it has 0% of its portfolio in CVS Health Corporation (NYSE:CVS). Newfocus Gp Limited stated it has 1.71% of its portfolio in CVS Health Corporation (NYSE:CVS).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>